GD vs PPCB · P/E 22, rev $52.55B vs P/E 0.0, $3.9M cap
General Dynamics Corporation (GD) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
General Dynamics Corporation (GD) is a aerospace & defense company listed on US.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported GD revenue for 2025-12-31 was $52.55B. Net income was $4.21B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. GD currently screens at market cap $93.69B and trailing P/E 21.8.
PPCB does not have a complete income-statement cache yet.
GD currently screens at market cap $93.69B and trailing P/E 21.8. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the GD and PPCB stock pages for the full models.
Not investment advice.